(1) As used in this part:(1) “Company” means a for-profit sole proprietorship, organization, association, corporation, partnership, joint venture, limited partnership, limited liability partnership, or limited liability company, including a wholly owned subsidiary, majority-owned subsidiary, parent company, or affiliate of such entities or business associations that exists to make a profit; or a nonprofit organization;(2) “Domicile” means the country in which:(A) A company is registered and the company's headquarters is located;(B) A majority of a company's affairs are conducted; or(C) The majority of a company's ownership shares are held;(3) “Forced organ harvesting” means the removal of one (1) or more organs from a living person or a person killed for the purpose of removal of one (1) or more organs by means of coercion, abduction, deception, fraud, or abuse of power or a position of vulnerability;(4) “Foreign adversary” means a nation specified in 15 CFR 791.4;(5) “Genetic sequencer” means a device or platform used to conduct genetic sequencing, resequencing, isolation, or other genetic research;(6) “Genetic sequencing” means a method to determine the identity and order of nucleotide bases in the human genome;(7) “Genomic research facility” means a facility that conducts research on, with, or relating to genetic sequencing or the human genome;(8) “Health benefit plan” means health insurance coverage as defined in § 56-7-109;(9) “Health insurer” means a health insurance entity as defined in § 56-7-109;(10) “Human genome” means deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) found in human cells;(11) “Medical facility” means a facility for the delivery of health services that:(A) Receives state funds, including interagency pass-through appropriations from the federal government;(B) Is licensed or registered with this state to provide healthcare services in this state; or(C) Conducts research or testing on, with, or relating to genetic sequencing or the human genome;(12) “Operational and research software” means computer programs used for the operation, control, analysis, or other necessary functions of genetic sequencing or genetic sequencers; and(13) “Software” means a program or routine that is used or intended for use to cause one (1) or more computers or pieces of computer-related peripheral equipment, or any combination of such equipment, to perform a task, as it relates to genetic sequencing or genetic sequencers.
(1) “Company” means a for-profit sole proprietorship, organization, association, corporation, partnership, joint venture, limited partnership, limited liability partnership, or limited liability company, including a wholly owned subsidiary, majority-owned subsidiary, parent company, or affiliate of such entities or business associations that exists to make a profit; or a nonprofit organization;
(2) “Domicile” means the country in which:(A) A company is registered and the company's headquarters is located;(B) A majority of a company's affairs are conducted; or(C) The majority of a company's ownership shares are held;
(A) A company is registered and the company's headquarters is located;
(B) A majority of a company's affairs are conducted; or
(C) The majority of a company's ownership shares are held;
(3) “Forced organ harvesting” means the removal of one (1) or more organs from a living person or a person killed for the purpose of removal of one (1) or more organs by means of coercion, abduction, deception, fraud, or abuse of power or a position of vulnerability;
(4) “Foreign adversary” means a nation specified in 15 CFR 791.4;
(5) “Genetic sequencer” means a device or platform used to conduct genetic sequencing, resequencing, isolation, or other genetic research;
(6) “Genetic sequencing” means a method to determine the identity and order of nucleotide bases in the human genome;
(7) “Genomic research facility” means a facility that conducts research on, with, or relating to genetic sequencing or the human genome;
(8) “Health benefit plan” means health insurance coverage as defined in § 56-7-109;
(9) “Health insurer” means a health insurance entity as defined in § 56-7-109;
(10) “Human genome” means deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) found in human cells;
(11) “Medical facility” means a facility for the delivery of health services that:(A) Receives state funds, including interagency pass-through appropriations from the federal government;(B) Is licensed or registered with this state to provide healthcare services in this state; or(C) Conducts research or testing on, with, or relating to genetic sequencing or the human genome;
(A) Receives state funds, including interagency pass-through appropriations from the federal government;
(B) Is licensed or registered with this state to provide healthcare services in this state; or
(C) Conducts research or testing on, with, or relating to genetic sequencing or the human genome;
(12) “Operational and research software” means computer programs used for the operation, control, analysis, or other necessary functions of genetic sequencing or genetic sequencers; and
(13) “Software” means a program or routine that is used or intended for use to cause one (1) or more computers or pieces of computer-related peripheral equipment, or any combination of such equipment, to perform a task, as it relates to genetic sequencing or genetic sequencers.